Fernand Labrie

Participation at SYMPOSIA

Page 4 of 11, showing 50 records out of 506 total, starting on record 151, ending on 200

Year(s) Title
1998 Annual Congress of the Société argentine de recherches cliniques, "Molecular Biology of Steroidogenesis in the Prostate and Mammary Gland", Mar del Lata, Argentina (November 1998)
2001 Annual Female Sexual Function Forum – Plenary and State-of-the-Art Lecture, “Role of Steroid Hormones as they Pertain to Female Sexual Functions”, Boston (October 2001)
2001 Annual Female Sexual Function Forum: Androgen Deficiency Syndrome in Women: Implications and Mechanisms and Treatments, “Role of Androgens and their Precursor DHEA in Women”, Boston (October 2001)
1981 Annual Meeting of the American Association for the Advancement of Science (AAAS), Symposium on Reproductive Biology and its Impact on Population, "Control of Gonadotropin Secretion", Toronto (January
2000 Annual Meeting of the Canadian Society of Endocrinology and Metabolism, Androgens and Antiandrogens in Clinical Endocrinology, “Inhibitors of Androgen Formation and Action in Prostatic Diseases”, Hali
1988 Annual Meeting of the Colegio Mexicano de Urologia, "Endocrine Therapy of Prostate Cancer", Guanajuato, Mexico (March 1988)
1985 Annual Meeting of the Institute of Chemistry of Canada, "The Development of a Two Drug Combination for the Treatment of Prostate Cancer", Kingston (June 1985)
1978 Annual Meeting of the Royal College and Canadian Society for Clinical Investigation, "Opiates and Neuroendocrine Control", Vancouver (January 1978)
1982 Annual Meeting of the Royal College of Gynecologists and Obstetricians of England, Jenniffer Hallam Lecturer, "The Possible Application of Man-Made Analogs of Luteinizing Hormone-Releasing Hormone in
1983 Annual Meeting of the Société d'endocrinologie française, "Nouveau traitement hormonal avec un agoniste de la LHRH et un antiandrogène dans le cancer de la prostate", Marseille (September 1983)
1992 Annual Meeting of the Urological Society of Australia (NSW Branch), "What is the Best Treatment for Prostate Cancer in October 1992?", Bowral, Australia (October 1992)
1981 Annual Symposium of the Secteur Nord de Montréal, "Moyens futurs dans la contraception chez l'homme et chez la femme", Montreal (November 1981)
1982 Annual Workshop on LHRH Analog, "Combined Treatment with an LHRH Agonist and an Antiandrogen in Prostatic Cancer, a New Approach", National Institute of Health, Bethesda (November 1982)
1984 Anti hormonal Treatment for Prostatic Cancer, Melbourne (August 1984)
2000 Aromatase 2000 and the Third Generation, “EM-652/SCH-57068: a Unique SERM having Pure Antiestrogenic Activity in the Mammary Gland and Endometrium”, Port Douglas, Australia (November 2000)
1993 Assises francophones de la recherche - Séminaire régional Canada-Québec, “La recherche francophone en sciences médicales: horizons nationaux et internationaux”, Montreal (September 1993)
1974 Association des médecins de langue française, Symposium d'endocrinologie, "Aspects de la physiologie de la sécrétion d'hormone de croissance", Québec City (October 1974)
1974 Association des médecins de langue française, Symposium d'endocrinologie, "Aspects de la physiologie du contrôle de l'ovulation", Québec City (October 1974)
1998 Association des Radio-oncologues du Québec, "Les avantages du dépistage du cancer de la prostate et le blocage androgénique combiné en radiothérapie", Québec (October 1998)
1996 Association of Clinical Biochemists, Prostate Disease and a Critical Evaluation of the Use of Prostate and Ovarian Tumor Markers in Laboratory and Clinical Medicine, "Is it Time to Reconsider Screenin
1992 Association of Urologist of New-Zealand, "What is the Best Treatment for Prostate Cancer in October 1992?", Auckland, New-Zealand (October 1992)
1998 Athenian Days of Urology 1998, "Efficacy, Pharmacological Effects and Quality of Life Achieved by Antiandrogens in Prostate Cancer Therapy. What's New?", Athens (May 1998)
2006 Biomedex 2006 – Success in technology transfer: the first 18 months – Proof of concept, Montreal, May 2006.
1981 Brook Lodge Symposium, "Therapeutic Applications for Peptides", Kalamazoo, (March 1981)
2002 Canadian Genomics Conference – Genome Canada, “Atlas of Genomic Profiles of Steroid Action”, Montreal (May 2002)
1998 Canadian Society of Clinical Chemists Med-Chem Lectureship, "Screening for Prostate Cancer. Its Impact on Cancer Death", Toronto (October 1998).
1988 Cancer Day Seminar on Prostatic Carcinoma Diagnosis and Management, "The Role of Hormonal Therapy in the Treatment of Prostatic Carcinoma", Detroit, Michigan (March 1988)
2006 CBI Conference on Menopause Pharmacotherapeutic Development “Tissue-specific HRT combining prevention of breast cancer”, Philadelphia, January 2006
1996 Centre anticancéreux de Caën : "Les enzymes de la stéroïdogénèse dans le testicule : de la biologie moléculaire à la clinique", Caën (May 1996)
1972 Chairman, Symposium of the Canadian Federation of Biological Societies, Québec City (June 1972)
1980 Chemical Methods for Male Fertility Control, "LHRH can Suppress Testicular Functions in Animals - is this a Feasible Approach in Men?", Bonn (October 1980)
1992 Chemotherapy Foundation Symposium X on Innovative Cancer Chemotherapy for Tomorrow, “Hormonal Therapy in Early Stage Prostate Cancer: Why and for How Long?”, New York, (November 1992)
1989 CIR (Canadian Investigators in Reproduction) Keynote Lecturer, "Role of Adrenal Steroids and Peripheral Estrogen Biosynthesis in Women", Québec City (June 1989)
1984 Collège de France "Résultats spectaculaires d'un nouveau traitement antihormonal du cancer de la prostate", Paris (May 1984)
1976 Colloque de synthèse des actions thématiques 22 et 35 de l'INSERM, "Interactions des estrogènes et des hormones thyroïdiennes dans le contrôle de la réponse de la TSH à la TRH", Lyon (October 1976)
1974 Conference of the Institut National de la Santé et de la Recherche Médicale, "Actions of the Hypothalamic Hormones", Paris (June 1974)
1975 Conference on Breast Cancer, "Effect of a New Antiestrogen on DMBA Induced Breast Cancer", Montreal (October 1975)
1981 Conference on L'Avenir du français dans les communications scientifiques, Montreal (November 1981)
1974 Conference on Neurobiology of CNS Hormone Interaction, "Polypeptide Receptor Mechanisms in Anterior Pituitary Gland", Chapel Hill, N.C. (May 1974)
1975 Conference on Prostaglandins, "Role of Prostaglandins in the Control of Anterior Pituitary Function", Vail, Colorado (March 1975)
1994 Congrès de l’ACFAS, La recherche et l’espoir, “Les cancers sensibles aux hormones: espoirs de nouvelles approches thérapeutiques”, Montreal (May 1994)
1977 Congrès mondial d'endocrinologie française, Opening Conference, "Rôle des oestrogènes dans l'activité de l'axe hypothalamo-hypophysaire", Marseille (September 1977)
1977 Congrès Mondial de Médecine Française, "Mechanism of Action of Hypothalamic Hormones", Paris (September 1977)
1979 Congress of Clinical Psychoneuroendocrinology, "Influence des estrogènes sur le système dopaminergique hypothalamique", Liège (September 1979)
2000 Congress of Greek Urological Association, « Antiandrogen and Prostatic Cancer », Athens (January 2000)
1984 Congress of l'Association des médecins de langue française du Canada, "Cancer de la prostate", Montreal (October 1984)
1982 Congress of l'Association des psychiatres du Québec, "Nouvelles implications de la neuroendocrinologie en psychiatrie", Montebello (June 1982)
1976 Congress of the German Society of Endocrinology, "Hypothalamic Relea-sing Hormones - their Mechanisms of Action", Bonn (March 1976)
1985 Congress of the International Study Group for Steroid Hormones, "Blockade of Testicular and Adrenal Androgens in Prostate Cancer", Rome (December 1985)
1995 Congress of the Philippine Urological Association: "Endocrine Therapy of Prostate Cancer", Manila (May 1995)
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards